Efficacy of Epalrestat, Duloxetine and Epalrestat in Combination with Methylcobalamine in Diabetic Peripheral Neuropathy
Diabetic neuropathy is a major long term problem allied with diabetes that can cause serious disability and also death. Fifty to seventy five percent of all ulcerations and non trauma amputations are a consequence of diabetic neuropathy. Epalrestat, duloxetine and epalrestat with methylcobalamine ar...
Main Authors: | Abhilash Penchala, Manasa Macharla, Subrahmanyam Bandaru Siva, Venkateshwarlu Eggadi, Goverdhan Puchchakayala, Nagesh Adla, Reddy Gade Amulya, Sharvana Bhava Bandaru Sheshagiri |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2016-12-01
|
Series: | Romanian Journal of Diabetes Nutrition and Metabolic Diseases |
Subjects: | |
Online Access: | http://www.degruyter.com/view/j/rjdnmd.2016.23.issue-4/rjdnmd-2016-0042/rjdnmd-2016-0042.xml?format=INT |
Similar Items
-
Duloxetine hydrochloride loaded film forming dermal gel enriched with methylcobalamin and geranium oil attenuates paclitaxel-induced peripheral neuropathy in rats
by: Simerjeet Kaur Chahal, et al.
Published: (2020-12-01) -
Clinical observation on the curative effect of epalrestat combined with compound anisodine in treatment of non-proliferative diabetic retinopathy
by: Xiu-Yun Gao, et al.
Published: (2019-06-01) -
Evaluation of renal function and oxidative stress after adjuvant epalrestat treatment of early diabetic nephropathy
by: Ge Zhao, et al.
Published: (2017-04-01) -
Epalrestat improves motor symptoms by reducing oxidative stress and inflammation in the reserpine induced mouse model of Parkinson’s disease
by: Md. Mahbubur Rahman, et al.
Published: (2020-03-01) -
Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy
by: Wang XT, et al.
Published: (2018-09-01)